Quarterly ResultApr 30, 2026, 07:37 AM
BCPC Q1 Net Sales +8.1% to $270.7M; Net Earnings +8.7% to $40.3M
AI Summary
Balchem Corporation reported record first-quarter 2026 financial results, with net sales increasing 8.1% to $270.7 million and GAAP net earnings rising 8.7% to $40.3 million. Adjusted EBITDA grew 12.1% to $74.3 million, and GAAP EPS was $1.25. All three segments (Human Nutrition & Health, Animal Nutrition & Health, Specialty Products) showed sales and earnings growth. The company also highlighted new clinical research on its VitaCholine® ingredient and released its 2025 Sustainability Report.
Key Highlights
- Net sales increased 8.1% to $270.7 million compared to the prior year quarter.
- GAAP net earnings rose 8.7% to $40.3 million from the prior year quarter.
- Adjusted EBITDA grew 12.1% to $74.3 million compared to the prior year quarter.
- GAAP diluted EPS was $1.25, up from $1.13 in the prior year quarter.
- Human Nutrition & Health segment sales increased 8.3% to $171.6 million.
- Animal Nutrition & Health segment sales increased 8.6% to $62.2 million.
- Specialty Products segment sales increased 4.4% to $34.7 million.
- Free cash flow was $33.8 million, with $40.1 million from operations.